SCHEMBL29645124

SCHEMBL29645124

C=CCc1c(O)cccc1C(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.42
MTNR1A P48039 1/20 0.40
CYP3A4 P08684 2/20 0.40
SRD5A1 P18405 1/20 0.40
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
GABRA1 P14867 1/20 0.37
GABRB2 P47870 1/20 0.37
TERT O14746 1/20 0.37
MAPT P10636 4/20 0.36
GAA P10253 1/20 0.36
CA1 P00915 1/20 0.36
CA9 Q16790 1/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HPGD P15428 2/20 0.36
HTT P42858 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17694444 1.00 THRB (0.42) THRBMTNR1ACYP3A4SRD5A1MAOA
SCHEMBL1325377 0.86 SRD5A1 (0.41) MTNR1ACYP3A4SRD5A1GABRA1GABRB2
SCHEMBL1079642 0.84 ACHE (0.39) THRBMTNR1ACYP3A4SRD5A1GABRA1
SCHEMBL1479090 0.84 ALDH1A1 (0.48) MTNR1ASRD5A1GABRA1GABRB2MAPT
SCHEMBL9543523 0.83 KDM4E (0.50) MTNR1ACYP3A4SRD5A1GABRA1GABRB2
SCHEMBL2430731 0.82 LMNA (0.54) MTNR1ACYP3A4GAACA1CA9
SCHEMBL27669490 0.81 MTNR1A (0.40) MTNR1ACYP3A4SRD5A1GABRA1GABRB2
SCHEMBL4987083 0.80 CA12 (0.54) CYP3A4MAOAMAOBMAPTCA1
SCHEMBL31657717 0.79 ALDH1A1 (0.48) MTNR1ASRD5A1MAOBGABRA1GABRB2
SCHEMBL9303754 0.79 ALDH1A1 (0.48) MTNR1ASRD5A1MAOBGABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250115604-A1 SULFOXIMINE GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2025-04-10 US disclosed
US-12157734-B2 Sulfoximine glycosidase inhibitors ASCENEURON SA (CH) 2024-12-03 US disclosed
CN-110770226-B Sulfoximine glycosidase inhibitors 阿森纽荣股份公司 2023-11-10 CN disclosed
US-20220177470-A1 SULFOXIMINE GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2022-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12157734-B2 Sulfoximine glycosidase inhibitors ENGASE, BACE1, GAA THRB 3063/4885MTNR1A 294/4885CYP3A4 1986/4885
US-20220177470-A1 SULFOXIMINE GLYCOSIDASE INHIBITORS ENGASE, BACE1, GAA THRB 3063/4885MTNR1A 294/4885CYP3A4 1986/4885
US-20250115604-A1 SULFOXIMINE GLYCOSIDASE INHIBITORS ENGASE, BACE1, GAA THRB 3027/4885MTNR1A 356/4885CYP3A4 2236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.